Results 271 to 280 of about 62,912 (312)

Efficacy and Safety of Tofacitinib in Palmoplantar Pustulosis: A Retrospective Study. [PDF]

Acta Derm Venereol
Lyu S, Xue X, Wang N, Liu H, Zhang F.
europepmc   +1 more source

Efficacy and Safety of Tofacitinib for Acute Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis. [PDF]

Gastroenterology Res
Brennan G, Meine GC, Delgado LM, Santo P.   +3 more
europepmc   +1 more source

The development of a clinical prediction model for response to methotrexate, tofacitinib, and etanercept in patients with Psoriatic Arthritis. [PDF]

Arthritis Res Ther
Perton FT, Bentvelzen MLM, Fadaei S, Pouw JN, Spierings J, Vonkeman HE, Mooij SC, Schipper LG, Herman A, TOFA-PREDICT author group, Mastbergen SC, Welsing PMJ.   +11 more
europepmc   +1 more source

Tofacitinib: A Promising Therapeutic Option for Refractory Pityriasis Rubra Pilaris-A Case Report. [PDF]

Clin Case Rep
Taremi M, Mozafari N.
europepmc   +1 more source

Pregnancy Outcomes After Maternal or Paternal Exposure to Tofacitinib Across Clinical Programs. [PDF]

Am J Gastroenterol
Mahadevan U, Chaparro M, Segovia M, Guo X, Kulisek N, Wu J, Vranic I, Diehl A, Kavanaugh A, Dubinsky M.   +9 more
europepmc   +1 more source

Topical Tofacitinib for Atopic Dermatitis - Outcomes from Randomized Phase 3 Clinical Trial: First Approval.

Indian J Dermatol
Chaturvedi AR, Zaveri HG, Patel DV, Tof-O in AD Trial Investigators.   +3 more
europepmc   +1 more source